CMS Proposes CLIA Changes on Virtual Access, Cytology PT and Personnel: A Practice Brief
A CMS proposed rule published October 8, 2026 would amend CLIA rules on virtual access, digital images for gynecologic cytology proficiency testing, personnel qualifications and reporting. What it covers and what to check.
On October 8, 2026, the Centers for Medicare & Medicaid Services (CMS), part of the Department of Health and Human Services, published a proposed rule in the Federal Register. The rule would amend the regulations under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), which govern federal oversight of clinical laboratories [1]. The document is number 2026-20613, titled "Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes" [1]. Because it is a proposed rule, it sets out changes CMS is putting forward, not requirements already in force [1].
What the proposal would do
The published summary describes the following changes [1]:
- Virtual access. Laboratories could use virtual access under the CLIA certificate of the primary testing laboratory that generated the data. The subspecialty of cytology is excluded [1].
- Gynecologic cytology proficiency testing (PT). The rule would allow digital images to be used for proficiency testing in gynecologic cytology [1].
- Personnel qualifications. The rule proposes changes to personnel qualification requirements. The summary does not say which roles or criteria would change [1].
- Other changes. Further proposals cover SARS-CoV-2 reporting requirements, certificate requirements, test reporting requirements, enforcement requirements and public consultation requirements, along with editorial and technical updates [1].
CMS states that the proposed updates aim to strengthen federal oversight of clinical laboratories and ensure accurate and reliable patient test results. It also says they would adapt to modern technological capabilities and to industry needs, including workforce shortages [1].
The summary does not explain how virtual access would operate beyond tying it to the certificate of the primary testing laboratory that generated the data [1]. The cytology provisions run in two directions: cytology is excluded from virtual access, while digital images are proposed for gynecologic cytology proficiency testing [1].
Scope
The proposal amends the CLIA regulations governing clinical laboratories [1]. The published summary does not identify specific categories of affected entities and does not discuss outpatient practices directly, so the scope for any individual practice has to be read from the full document [1].
Dates that matter
The proposed rule was published on October 8, 2026 [1]. The summary does not give a comment deadline, a proposed effective date or any compliance dates, so those must be taken from the full Federal Register document [1]. Because the changes are proposed, publication on its own does not alter what a laboratory must do under the current CLIA regulations [1].
What a practice should check
- If the practice holds a CLIA certificate, read the proposed changes to certificate requirements in the full document [1].
- If the practice employs laboratory personnel, compare current staffing against the proposed changes to personnel qualification requirements once the detail is read in the full document [1].
- Review the proposed changes to test reporting requirements in the full document [1].
- If the practice performs SARS-CoV-2 testing, read the proposed changes to SARS-CoV-2 reporting requirements [1].
- Where the practice works with other laboratories, note that the proposed virtual access provision is tied to the certificate of the primary testing laboratory that generated the data and excludes cytology [1].
- Read the proposed changes to enforcement requirements in the full document [1].
- Find the comment deadline and submission instructions in the full document so the practice, or its professional association, can decide whether to comment [1].
Limitations
This brief draws on the summary published with the proposed rule, not the full regulatory text [1]. The summary gives no cost or burden estimates and no dates beyond publication, and it omits the detail of the personnel, certificate, reporting and enforcement changes, any of which could change a practice's assessment [1]. Other recent Federal Register documents cover separate subjects, including a final rule on price transparency reporting by group health plans and health insurance issuers [2] and a final rule updating fiscal year 2027 payment rates for inpatient rehabilitation facilities [3].
References
- federalregister.gov. Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes. Accessed October 8, 2026. federalregister.gov
- federalregister.gov. Transparency in Coverage. Accessed October 8, 2026. federalregister.gov
- federalregister.gov. Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program. Accessed October 8, 2026. federalregister.gov
How this was written: drafted with AI from the sources listed above, then checked automatically, claim by claim, against them before publishing. The iPMS Practice Desk covers the business and operations of independent practices: payment, documentation, efficiency, productivity and managing the team. It reads federal rules, CMS and HHS notices and published research so practices do not have to. Every factual statement links to its source.